
Organic Process Research and Development p. 670 - 685 (2020)
Update date:2022-08-04
Topics:
Hardouin, Christophe
Baillard, Sandrine
Barière, Fran?ois
Craquelin, Anthony
Grandjean, Mathieu
Janvier, Solenn
Le Roux, Stéphane
Penloup, Christine
Russo, Olivier
This paper describes the synthesis of kilogram quantities of the sulfonamide moiety 3 involved in a coupling reaction with acid moiety 2 to provide batches of drug candidate 1 for preclinical studies and first-in-human clinical trials. A first approach relying on a chiral separation furnished the desired enantiomer of 1,3-diamine 20, precursor of sulfonamide 3. An enantiomeric synthesis of 20 using the Ellman's chiral auxiliary coupled with an aza-Reformatsky reaction to control the stereochemistry is also discussed. Coupling conditions of the final step involving EDCI to provide 1 under a cGMP process are detailed. An alternative approach using N-(1-methanesulfonyl)benzotriazole is also presented.
View MoreLanzhou huibang biological chemical technology Co., LTD
Contact:0931-7843964
Address:NO.2011,Yannan Road,Chengguan,
Ceresking Ecology & Technology co.,ltd
Contact:86 22 66218397
Address:Room 1613, Zheshang Mansion, No. 1988, Yingbin Avenue, Binhai New District, Tianjin,China.
PINGYUAN SIHUAN PHARMACEUTICAL CO., LTD
Contact:+86-531-55696072
Address:#2766,yinxiu Road, Economic Development Zone, Pingyuan Country, Shandong Province, China.
He Bei Shun Er Chemical Co., LTD.
Contact:86-0311-86996932/86860168
Address:No 18,North street
Wuhan Chemchemical Co., Ltd.(expird)
Contact:15973022782
Address:7-5-6218,Incubation Centre,Guandong Industry Park, East Lake High-Tech Development Zone,Wuhan City.
Doi:10.1016/j.jorganchem.2008.04.023
(2008)Doi:10.1016/S0040-4039(00)95115-3
(1985)Doi:10.1039/c39860000757
(1986)Doi:10.1002/chem.201501823
(2015)Doi:10.1039/c1gc15701a
(2011)Doi:10.1002/jhet.5570450420
(2008)